Fulcrum Therapeutics Inc.

NASDAQ: FULC · Real-Time Price · USD
7.50
0.12 (1.63%)
At close: Jun 27, 2025, 9:37 AM
1.63%
Bid 7.39
Market Cap 405.11M
Revenue (ttm) 80M
Net Income (ttm) -510K
EPS (ttm) -0.01
PE Ratio (ttm) -750.5
Forward PE n/a
Analyst Hold
Ask 7.67
Volume 25,522
Avg. Volume (20D) 562,901
Open 7.43
Previous Close 7.38
Day's Range 7.34 - 7.54
52-Week Range 2.31 - 10.13
Beta 2.42

About FULC

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FULC
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for FULC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
+17.23%
Fulcrum Therapeutics shares are trading higher aft... Unlock content with Pro Subscription
9 months ago
+15.27%
Fulcrum Therapeutics shares are trading higher after Pfizer withdrew its sickle cell treatment.